Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Shares Issued: 2022-2023

Historic Shares Issued for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $100.2 million.

  • Lexeo Therapeutics' Shares Issued rose 357757.14% to $100.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $100.3 million, marking a year-over-year change of. This contributed to the annual value of $88.7 million for FY2024, which is 11.51% down from last year.
  • Per Lexeo Therapeutics' latest filing, its Shares Issued stood at $100.2 million for Q4 2023, which was up 333,900.00% from $30,000 recorded in Q3 2023.
  • Lexeo Therapeutics' 5-year Shares Issued high stood at $100.2 million for Q4 2023, and its period low was $9,000 during Q2 2023.
  • For the 2-year period, Lexeo Therapeutics' Shares Issued averaged around $20.1 million, with its median value being $28,000 (2022).
  • Data for Lexeo Therapeutics' Shares Issued shows a peak YoY soared of 357,757.14% (in 2023) over the last 5 years.
  • Lexeo Therapeutics' Shares Issued (Quarterly) stood at $28,000 in 2022, then soared by 357,757.14% to $100.2 million in 2023.
  • Its Shares Issued stands at $100.2 million for Q4 2023, versus $30,000 for Q3 2023 and $9,000 for Q2 2023.